Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Surg. 2013 Dec;206(6):979-85; discussion 985-6. doi: 10.1016/j.amjsurg.2013.08.017. Epub 2013 Oct 12.

Preoperative imaging for early-stage cutaneous melanoma: predictors, usage, and utility at a single institution.

Author information

1
Department of Surgery, Mayo Clinic in Arizona, 5777 East Mayo Boulevard, Scottsdale, AZ 85250, USA.

Abstract

BACKGROUND:

Preoperative imaging for early-stage cutaneous melanoma is not recommended by current guidelines. Our goal was to investigate our institutional usage and utility.

METHODS:

Patients with clinically node-negative cutaneous melanoma undergoing surgery with sentinel lymph node biopsy were identified retrospectively. Any melanoma-related imaging after diagnosis and before surgery was considered a staging study.

RESULTS:

Five hundred fifteen studies were performed in 409 of 546 (75%) patients. Chest x-rays was performed in 70% and advanced imaging in 14% (computed tomography imaging, magnetic resonance imaging, ultrasound, and positron-emission computed tomography imaging). No metastatic lesions were identified. A Breslow thickness greater than 4 mm (odds ratio = 6.46 vs <1 mm; 95% confidence interval, 2.07 to 20.15) and male sex (odds ratio = 2.62 vs female; 95% confidence interval, 1.26 to 5.46) were associated with an increased likelihood of advanced imaging.

CONCLUSIONS:

Preoperative imaging was performed in the majority of patients with node-negative melanoma, with 14% undergoing advanced studies. No metastatic lesions were identified, confirming the limited utility in this setting.

KEYWORDS:

Melanoma; Preoperative imaging; Staging

PMID:
24124660
DOI:
10.1016/j.amjsurg.2013.08.017
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center